Relevance of neo- or adjuvant pretreatment in patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab as first-line treatment – data from the prospective TKK registry. 7. Juni 2015 Schnell, R., Trarbach, T., Broszeit-Luft, S., Musch, R., Wetzel, N., Kopfmann, S., Jänicke, M., Marschner, N., 2015. Oncol Res Treat 38 (suppl 5)(V395), 114. doi:10.1159/000439070 Abstract Implementation of RAS testing in patients with metastatic colorectal cancer in German outpatient cancer centers – data from the clinical TKK registry. Schnell, R., Trarbach, T., Broszeit-Luft, S., Musch, R., Frank, M., Kopfmann, S., Jänicke, M., Marschner, N., 2015. Oncol Res Treat 38 (suppl 5)(V394), 113–114. doi:10.1159/000439070… Weiterlesen Chemotherapy-induced nausea and vomiting – treatment and patient-reported outcomes in German outpatient cancer centres: Final data from the Emesis-Registry. Schröder, J., Wiegand, J., Dörfel, S., Jähnich, S., Boller, E., Marschner, N., 2015. Support Care Cancer 23(Suppl. 1), S139. doi:10.1007/s00520-015-2712-y… Weiterlesen